Single nucleus DNA sequencing of flow sorted archived frozen and formalin fixed paraffin embedded solid tumors.
FFPE tissue
Flow cytometry
Ovarian cancer
Single nucleus sequencing
Journal
BMC genomics
ISSN: 1471-2164
Titre abrégé: BMC Genomics
Pays: England
ID NLM: 100965258
Informations de publication
Date de publication:
08 Oct 2024
08 Oct 2024
Historique:
received:
15
07
2024
accepted:
30
09
2024
medline:
9
10
2024
pubmed:
9
10
2024
entrez:
8
10
2024
Statut:
epublish
Résumé
Archived samples, including frozen and formalin fixed paraffin embedded (FFPE) tissues, are a vast resource of clinically annotated materials for the application of high-definition genomics to improve patient management and provide a molecular basis for the delivery of personalized cancer therapeutics. Notably, FFPE tissues are stable, provide repeat sampling of tissues of interest, and can be stored indefinitely at ambient temperature. The development of single cell DNA sequencing (scDNA-seq) technologies provides an unparalleled opportunity for the study of tumor heterogeneity and the identification of often rare subclonal cell populations that drive tumor evolution and progression to advanced therapy resistant disease. However, major limitations to the use of archived tissues for scDNA-seq include the low yields of intact cells in the presence of high levels of subcellular debris in biopsies, and the highly variable quantity and quality of the DNA extracted from samples of interest. The latter is of high significance for the use of FFPE tissues due to the presence of DNA-protein crosslinks. In addition, many samples, notably tumors arising in solid tissues, contain admixtures of reactive stroma, inflammatory cells, and necrosis in immediate contact with tumor cells. To expand their use for translational studies, we optimized flow sorting and sequencing of single nuclei from archived fresh frozen (FF) and FFPE tumor tissues. Our methods, which include isolation of intact nuclei suitable for library preparations, quality control (QC) metrics for each step, and a single cell sequencing bioinformatic processing and analysis pipeline, were validated with flow sorted nuclei from matching FF and FFPE ovarian cancer surgical samples and a sequencing panel of 553 amplicons targeting single nucleotide and copy number variants in genes of interest. Our flow sorting based protocol provides intact nuclei suitable for snDNA-seq from archival FF and FFPE tissues. Furthermore, we have developed QC steps that optimize the preparation and selection of samples for deep single cell clonal profiling. Our data processing pipeline captures rare subclones in tumors with highly variable genomes based on variants in genes of interest.
Sections du résumé
BACKGROUND
BACKGROUND
Archived samples, including frozen and formalin fixed paraffin embedded (FFPE) tissues, are a vast resource of clinically annotated materials for the application of high-definition genomics to improve patient management and provide a molecular basis for the delivery of personalized cancer therapeutics. Notably, FFPE tissues are stable, provide repeat sampling of tissues of interest, and can be stored indefinitely at ambient temperature. The development of single cell DNA sequencing (scDNA-seq) technologies provides an unparalleled opportunity for the study of tumor heterogeneity and the identification of often rare subclonal cell populations that drive tumor evolution and progression to advanced therapy resistant disease. However, major limitations to the use of archived tissues for scDNA-seq include the low yields of intact cells in the presence of high levels of subcellular debris in biopsies, and the highly variable quantity and quality of the DNA extracted from samples of interest. The latter is of high significance for the use of FFPE tissues due to the presence of DNA-protein crosslinks. In addition, many samples, notably tumors arising in solid tissues, contain admixtures of reactive stroma, inflammatory cells, and necrosis in immediate contact with tumor cells.
RESULTS
RESULTS
To expand their use for translational studies, we optimized flow sorting and sequencing of single nuclei from archived fresh frozen (FF) and FFPE tumor tissues. Our methods, which include isolation of intact nuclei suitable for library preparations, quality control (QC) metrics for each step, and a single cell sequencing bioinformatic processing and analysis pipeline, were validated with flow sorted nuclei from matching FF and FFPE ovarian cancer surgical samples and a sequencing panel of 553 amplicons targeting single nucleotide and copy number variants in genes of interest.
CONCLUSIONS
CONCLUSIONS
Our flow sorting based protocol provides intact nuclei suitable for snDNA-seq from archival FF and FFPE tissues. Furthermore, we have developed QC steps that optimize the preparation and selection of samples for deep single cell clonal profiling. Our data processing pipeline captures rare subclones in tumors with highly variable genomes based on variants in genes of interest.
Identifiants
pubmed: 39379794
doi: 10.1186/s12864-024-10850-w
pii: 10.1186/s12864-024-10850-w
doi:
Substances chimiques
Formaldehyde
1HG84L3525
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
943Informations de copyright
© 2024. The Author(s).
Références
Shendure J, Ji H. Next-generation DNA sequencing. Nat Biotechnol. 2008;26:1135–45.
doi: 10.1038/nbt1486
pubmed: 18846087
Metzker ML. Sequencing technologies - the next generation. Nat Rev Genet. 2010;11:31–46.
doi: 10.1038/nrg2626
pubmed: 19997069
Serth J, Kuczyk MA, Paeslack U, Lichtinghagen R, Jonas U. Quantitation of DNA extracted after micropreparation of cells from frozen and formalin-fixed tissue sections. Am J Pathol. 2000;156:1189–96.
doi: 10.1016/S0002-9440(10)64989-9
pubmed: 10751344
pmcid: 1876866
Shi SR, et al. DNA extraction from archival formalin-fixed, paraffin-embedded tissue sections based on the antigen retrieval principle: heating under the influence of pH. J Histochem Cytochem. 2002;50:1005–11.
doi: 10.1177/002215540205000802
pubmed: 12133903
Srinivasan M, Sedmak D, Jewell S. Effect of fixatives and tissue processing on the content and integrity of nucleic acids. Am J Pathol. 2002;161:1961–71.
doi: 10.1016/S0002-9440(10)64472-0
pubmed: 12466110
pmcid: 1850907
Wu L, Patten N, Yamashiro CT, Chui B. Extraction and amplification of DNA from formalin-fixed, paraffin-embedded tissues. Appl Immunohistochem Mol Morphol. 2002;10:269–74.
doi: 10.1097/00129039-200209000-00015
pubmed: 12373156
Weir BA, et al. Characterizing the cancer genome in lung adenocarcinoma. Nature. 2007;450:893–8.
doi: 10.1038/nature06358
pubmed: 17982442
pmcid: 2538683
Paris PL, et al. High-resolution analysis of paraffin-embedded and formalin-fixed prostate tumors using comparative genomic hybridization to genomic microarrays. Am J Pathol. 2003;162:763–70.
doi: 10.1016/S0002-9440(10)63873-4
pubmed: 12598311
pmcid: 1868117
Paris PL, et al. High resolution oligonucleotide CGH using DNA from archived prostate tissue. Prostate. 2007;67:1447–55.
doi: 10.1002/pros.20632
pubmed: 17654530
pmcid: 2844769
McMahon CM, et al. Clonal selection with RAS pathway activation mediates secondary clinical resistance to selective FLT3 inhibition in acute myeloid leukemia. Cancer Discov. 2019;9:1050–63.
doi: 10.1158/2159-8290.CD-18-1453
pubmed: 31088841
Robinson TM, et al. Single-cell genotypic and phenotypic analysis of measurable residual disease in acute myeloid leukemia. Sci Adv. 2023;9: eadg0488.
doi: 10.1126/sciadv.adg0488
pubmed: 37729414
pmcid: 10881057
Yaeger R, et al. Molecular characterization of acquired resistance to KRASG12C-EGFR inhibition in colorectal cancer. Cancer Discov. 2023;13:41–55.
doi: 10.1158/2159-8290.CD-22-0405
pubmed: 36355783
Zhao Y, et al. Diverse alterations associated with resistance to KRAS(G12C) inhibition. Nature. 2021;599:679–83.
doi: 10.1038/s41586-021-04065-2
pubmed: 34759319
pmcid: 8887821
Zhang H, et al. Application of high-throughput single-nucleus DNA sequencing in pancreatic cancer. Nat Commun. 2023;14:749.
doi: 10.1038/s41467-023-36344-z
pubmed: 36765116
pmcid: 9918733
Nadeu F, et al. Detection of early seeding of Richter transformation in chronic lymphocytic leukemia. Nat Med. 2022;28:1662–71.
doi: 10.1038/s41591-022-01927-8
pubmed: 35953718
pmcid: 9388377
Holley T, et al. Deep clonal profiling of formalin fixed paraffin embedded clinical samples. PLoS One. 2012;7: e50586.
doi: 10.1371/journal.pone.0050586
pubmed: 23226320
pmcid: 3511535
Ruiz C, et al. Advancing a clinically relevant perspective of the clonal nature of cancer. Proc Natl Acad Sci U S A. 2011;108:12054–9.
doi: 10.1073/pnas.1104009108
pubmed: 21730190
pmcid: 3141975
Barrett MT, et al. Clinical study of genomic drivers in pancreatic ductal adenocarcinoma. Br J Cancer. 2017;117:572–82.
doi: 10.1038/bjc.2017.209
pubmed: 28720843
pmcid: 5558689
Lenkiewicz E, et al. Genomic and epigenomic landscaping defines new therapeutic targets for adenosquamous carcinoma of the pancreas. Cancer Res. 2020;80:4324–34.
doi: 10.1158/0008-5472.CAN-20-0078
pubmed: 32928922
pmcid: 7906529
Lipson D, Aumann Y, Ben-Dor A, Linial N, Yakhini Z. Efficient calculation of interval scores for DNA copy number data analysis. J Comput Biol. 2006;13:215–28.
doi: 10.1089/cmb.2006.13.215
pubmed: 16597236
MissionBio. 2024. In https://support.missionbio.com/hc/en-us/articles/360038950934-Step-1-Preflight-checks-QC .
Martin M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet. journal. 2011;17(1):10–2.
Rabinovitch PS. DNA content histogram and cell-cycle analysis. Methods Cell Biol. 1994;41:263–96.
doi: 10.1016/S0091-679X(08)61723-9
pubmed: 7861967
Galipeau PC, et al. NSAIDs modulate CDKN2A, TP53, and DNA content risk for progression to esophageal adenocarcinoma. PLoS Med. 2007;4: e67.
doi: 10.1371/journal.pmed.0040067
pubmed: 17326708
pmcid: 1808095
Loo LW, et al. Array comparative genomic hybridization analysis of genomic alterations in breast cancer subtypes. Cancer Res. 2004;64:8541–9.
doi: 10.1158/0008-5472.CAN-04-1992
pubmed: 15574760
Maley CC, et al. Genetic clonal diversity predicts progression to esophageal adenocarcinoma. Nat Genet. 2006;38:468–73.
doi: 10.1038/ng1768
pubmed: 16565718
Zhou Y, et al. Genomic landscape of diploid and aneuploid microsatellite stable early onset colorectal cancer. Sci Rep. 2024;14:9368.
doi: 10.1038/s41598-024-59398-5
pubmed: 38654044
pmcid: 11039710
Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011;474:609–15.
doi: 10.1038/nature10166
Van der Auwera GA, O’Connor BD. Genomics in the cloud. Sebastopol: O’Reilly Media, Inc.; 2020.
Caetano-Anolles D. 2024. In https://gatk.broadinstitute.org/hc/en-us .
Pellegrino M, et al. High-throughput single-cell DNA sequencing of acute myeloid leukemia tumors with droplet microfluidics. Genome Res. 2018;28:1345–52.
doi: 10.1101/gr.232272.117
pubmed: 30087104
pmcid: 6120635
Wright Muelas M, Mughal F, O’Hagan S, Day PJ, Kell DB. The role and robustness of the Gini coefficient as an unbiased tool for the selection of Gini genes for normalising expression profiling data. Sci Rep. 2019;9:17960.
doi: 10.1038/s41598-019-54288-7
pubmed: 31784565
pmcid: 6884504
Bass AJ, et al. Genomic sequencing of colorectal adenocarcinomas identifies a recurrent VTI1A-TCF7L2 fusion. Nat Genet. 2011;43:964–8.
doi: 10.1038/ng.936
pubmed: 21892161
pmcid: 3802528
Gerlinger M, et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med. 2012;366:883–92.
doi: 10.1056/NEJMoa1113205
pubmed: 22397650
pmcid: 4878653
Jewell SD, et al. Analysis of the molecular quality of human tissues: an experience from the cooperative human tissue network. Am J Clin Pathol. 2002;118:733–41.
doi: 10.1309/VPQL-RT21-X7YH-XDXK
pubmed: 12428794
Jones S, et al. Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science. 2008;321:1801–6.
doi: 10.1126/science.1164368
pubmed: 18772397
pmcid: 2848990
Chen M, et al. JAK2 and PD-L1 amplification enhance the dynamic expression of PD-L1 in triple-negative breast cancer. Clin Breast Cancer. 2018;18:e1205–15.
doi: 10.1016/j.clbc.2018.05.006
pubmed: 29933930
Phung TN, et al. Unique evolutionary trajectories of breast cancers with distinct genomic and spatial heterogeneity. Sci Rep. 2021;11:10571.
doi: 10.1038/s41598-021-90170-1
pubmed: 34011996
pmcid: 8134446
Navin N, et al. Tumour evolution inferred by single-cell sequencing. Nature. 2011;472:90–4.
doi: 10.1038/nature09807
pubmed: 21399628
pmcid: 4504184
Barrett MT, et al. Evolution of neoplastic cell lineages in Barrett oesophagus. Nat Genet. 1999;22:106–9.
doi: 10.1038/8816
pubmed: 10319873
pmcid: 1559997